Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06114017 · ClinicalTrials.gov registry record · NA

Effect of a Week-long Social Media Abstention on Sustained Attention Functions

A NA study of Attention Difficulties, sponsored by New York Institute of Technology.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT06114017: Recruiting NA study of Attention Difficulties, sponsored by New York Institute of Technology.

NCT06114017 is a NA study of Attention Difficulties that is actively recruiting participants, run by New York Institute of Technology. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06114017, a NA study of Attention Difficulties, is actively recruiting participants, sponsored by New York Institute of Technology.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The current study's goal is to determine if a one-week break from social media in all forms has a beneficial effect on people's attention, as measured by the Sustained Attention to Response Task, executive function as measured by the Stroop test, and well-being.

Conditions Studied

Interventions

  • BEHAVIORAL Social Media Abstention

Study Locations (1)

New York

  • NYIT - Old Westbury

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2023-08-29
Est. Completion 2024-08-31
Phase NA
New York Institute of Technology

49 total trials

What NCT06114017 shows while recruiting

NCT06114017 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Attention Difficulties appearing as the primary indexed condition, and to 1 intervention - of which Social Media Abstention is the first listed.

NCT06114017 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT06114017 about?

NCT06114017 is a clinical study titled "Effect of a Week-long Social Media Abstention on Sustained Attention Functions". The current study's goal is to determine if a one-week break from social media in all forms has a beneficial effect on people's attention, as measured by the Sustained Attention to Response Task, executive function as measured by the Stroop test, and well-being.

What is the current status of trial NCT06114017?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2023-08-29. Estimated completion is 2024-08-31.

What conditions does trial NCT06114017 study?

This clinical trial studies the following conditions: Attention Difficulties.

What interventions are being tested in trial NCT06114017?

The interventions under investigation include: Social Media Abstention (BEHAVIORAL).

Who is sponsoring clinical trial NCT06114017?

This trial is sponsored by New York Institute of Technology, which has 49 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06114017 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Attention Difficulties

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06114017's enrollment target sits among peer trials

50 1280th of 2000 higher than 622 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06114017, the US trial registry maintained by the National Library of Medicine. NCT06114017 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.